Stock AnalizAgilent Technologies, Inc. A
Biotechnology: Laboratory Analytical Instruments · IPO 1999 · data as of November 13, 2026
Agilent Technologies, Inc. (A) is a industrial company listed in the US with a market value of about $49.0B. In the twelve months to July 31, 2026 it had revenue of $7.4B and net income of $1.4B, a net margin of 19.5%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is shareholder returns (5/5); the weakest is value (0/5).
Key numbers: a P/E of 34.3, a price to free cash flow of 38.7, 5-year revenue growth of 5% a year, a 5-year average ROIC of 14%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 42% below the current price.
Score: 2.6 / 5
Checks passed
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
- Interest covered more than 5 times
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4B | $6.9B | $6.5B | $6.8B | $6.8B | $6.3B | $5.3B | $5.2B | $4.9B | $4.5B | $4.2B |
| Net income | $1.4B | $1.3B | $1.3B | $1.2B | $1.3B | $1.2B | $719M | $1.1B | $316M | $684M | $462M |
| Free cash flow | $1.3B | $1.2B | $1.4B | $1.5B | $1.0B | $1.3B | $802M | $866M | $910M | $713M | $654M |
| EPS (diluted) | $5.07 | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | $0.97 | $2.10 | $1.40 |
| Net margin | 19.5% | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | 6.4% | 15.3% | 11.0% |
| ROIC | — | 13.5% | 13.4% | 14.3% | 16.5% | 14.4% | 9.8% | 10.4% | 11.2% | 10.3% | 9.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 20 analysts is $182.05, 5% above the current price; targets range from $155.00 to $200.00; the consensus rating is “Buy”; expected EPS is $6.20 for the fiscal year ending October 31, 2026.
Frequently asked questions
What is Agilent Technologies’s P/E ratio?
About 34.3, based on the last twelve months of diluted earnings per share (forward P/E about 26.4).
Is Agilent Technologies stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 42% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Agilent Technologies pay a dividend?
Yes. The dividend yield is about 0.58%, and it has paid dividends for 10 years in our data.
Is Agilent Technologies a good stock to buy?
We do not give buy or sell advice. Agilent Technologies scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.